GlobeNewsWire
04 Aug 2026, 03:05 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
1 claim · each scored for market impact
Abbott Cooper PLLC is investigating potential breaches of fiduciary duty by the board of directors of Kalaris Therapeutics, Inc. (KLRS). — Legal investigations into board misconduct create governance risk and potential liability for the company, which typically weighs on share prices.
-0.30Which stocks this story touches
The company is under investigation for potential breaches of fiduciary duties by its board of directors.
The company is the subject of an investigation into possible fiduciary duty claims.
Continue reading
6 related stories
Search tags
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Business Wire
5h ago
